María Lola Evia-Viscarra

María Lola Evia-Viscarra

Auto-generated profile, based on publicly available information

María Lola Evia-Viscarra

Department of Pediatric Endocrinology, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR) , Hospital Regional de Alta Especialidad del Bajío , León , México

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2014 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
Edel Rafael Rodea-MonteroEdel Rafael Rodea-Montero
Edel Rafael Rodea-Montero
MEMaría Lola Evia-Viscarra
María Lola Evia-Viscarra
EAEvelia Apolinar-Jiménez
Evelia Apolinar-Jiménez
Objective. To identify the degree of association between anthropometric indices and components of metabolic syndrome (MS) and to determine optimal cut-off points of these indices for predicting MS in obese adolescents.Methods. A cross-sectional study with a sample of (n=110) Mexican obese adolescents grouped by sex and the presence/absence of MS. BMI percentile, waist circumference (WC), and waist-to-height ratio (WHtR) were tested. ROC curves of the anthropometric indices were created to identify whether an index was a significant predictor of MS.Results. BMI percentile, WC, and WHtR were significantly correlated with systolic and diastolic blood pressure. As predictors of MS overall patients, the BMI percentile generated an area under curve (AUC) of 0.651 (P=0.008), cut-off point above the 99th percentile. WC generated an AUC of 0.704 (P<0.001), cut-off point of ≥90 cm. WHtR demonstrated an AUC of 0.652 (P=0.008), cut-off point of 0.60. WHtR ≥0.62 and WHtR ≥0.61 generate AUC of 0.737 (P=0.006) and AUC of 0.717 (P=0.014) for predicting hypertension and insulin resistance, respectively, in females.Conclusion. WHtR is a better tool than WC and BMI for identifying cardiometabolic risk. The overall criterion (WHtR ≥ 0.6) could be appropriate for predicting MS in obese Mexican adolescents.

1 January 2012 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
MEMaria Lola Evia-Viscarra
Maria Lola Evia-Viscarra
Edel Rafael Rodea-MonteroEdel Rafael Rodea-Montero
Edel Rafael Rodea-Montero
EAEvelia Apolinar-Jiménez
Evelia Apolinar-Jiménez
NMNathalie Muñoz-Noriega
Nathalie Muñoz-Noriega
LGLeticia Margarita García-Morales
Leticia Margarita García-Morales
JRJuan Gerardo Reyes-García
Juan Gerardo Reyes-García
To compare serum concentrations of inflammatory cytokines, interleukin 6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), adiponectin, and tumor necrosis factor alpha (TNFalpha), before and after 3 months treatment with metformin in obese adolescents with insulin resistance (IR). This was a randomized, double-blinded, clinical trial of two groups of obese adolescents with IR, aged 9-18 years: a placebo group (n=14) and a metformin group (n=12) who received 500 mg metformin every 12 h for 3 months. Anthropometric and biochemical (metabolic and inflammatory cytokines) assessments were compared at the beginning and end of treatment. After 3 months of treatment, body mass index (kg/m2) was reduced in both groups: placebo group (32.82 +/- 6.37-32.10 +/- 6.52; p=0.011) and metformin group (33.44 +/- 5.82-32.71 +/- 5.77; p=0.015). Serum fasting insulin concentrations (pmol/L) increased in the placebo group (189.45 +/- 112.64-266.06 +/- 167.79; p=0.01) and showed a slight decrease in the metformin group (256.82 +/- 113.89-229.25 +/- 86.53; p=0.64). Adiponectin concentrations (microg/mL) decreased in the placebo group (13.17 +/- 7.31-5.65 +/- 6.69; p=0.02), while these remained stable in the metformin group (8.57 +/- 3.98-7.86 +/- 6.23; p=0.64). In the metformin group, significant reductions were found in the variances of serum TNFalpha concentrations (p=0.006; Levene test). These results suggest that treating obese adolescents with IR using metformin for 3 months is an option for patients without response to traditional lifestyle change because metformin improves inflammatory activity, which is an etiological factor in cardiovascular disease development.

21 February 2007 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
RVR.A. Valdés‐González
R.A. Valdés‐González
DWD.J.G. White
D.J.G. White
LDL.M. Dorantes
L.M. Dorantes
LTL. Terán
L. Terán
GGG.N. Garibay‐Nieto
G.N. Garibay‐Nieto
BRB. Ramírez‐González
B. Ramírez‐González

1 March 2020 in Metabolism
Verified
Journal Article
Closed access
RGRodolfo Guardado-Mendoza
Rodolfo Guardado-Mendoza
SSSara Stephania Salazar-López
Sara Stephania Salazar-López
MÁMildred Álvarez-Canales
Mildred Álvarez-Canales
DFDiana Farfán-Vázquez
Diana Farfán-Vázquez
YMYoscelina Estrella Martínez-López
Yoscelina Estrella Martínez-López
AAAlberto Aguilar-García
Alberto Aguilar-García

1 January 2005 in Transplantation Proceedings
Verified
Journal Article
Closed access
DTD. Terán-Escandón
D. Terán-Escandón
LTL. Terán-Ortiz
L. Terán-Ortiz
COC. Ormsby-Jenkins
C. Ormsby-Jenkins
MEM.L. Evia-Viscarra
M.L. Evia-Viscarra
DWD.J.G. White
D.J.G. White
RVR. Valdés-González-Salas
R. Valdés-González-Salas

1 December 2013 in Endocrine Connections
Verified
Journal Article
Open access
PDF file
MEMaria Lola Evia-Viscarra
Maria Lola Evia-Viscarra
Edel Rafael Rodea-MonteroEdel Rafael Rodea-Montero
Edel Rafael Rodea-Montero
EAEvelia Apolinar-Jiménez
Evelia Apolinar-Jiménez
SQSilvia Quintana-Vargas
Silvia Quintana-Vargas
The aim of this study was to estimate the prevalence of metabolic syndrome (MS) and its components in obese Mexican adolescents and to compare the clinical, anthropometric, and biochemical characteristics between patients with and without MS by sex. We conducted a cross-sectional study with a sample of 110 obese adolescents (boys and girls) from 8 to 16 years old (BMI ≥95th percentile), who were recruited in the pediatric obesity clinic of a third-level care hospital. A frequency analysis was used to estimate the prevalence of MS and its components, and the assessments were compared between the sexes and between the groups with and without MS using the Kruskal–Wallis test. The prevalence of MS was 62%. In order of prevalence, the following components of MS were observed in the sample: abdominal obesity (88%), high triglycerides (TG) (85%), low HDL-C (60%), hypertension (35%), and hyperglycemia (5%). In the groups with MS, hypertension (P<0.001), waist circumference (P=0.003), and TG (P=0.012) were significantly higher, and HDL-C (P<0.001) was significantly lower. In conclusion the prevalence of MS and its components is high among obese Mexican-Hispanic children. These findings show the importance of preventing and treating obesity in the early stages of life in order to decrease the incidence rates of cardiovascular disease and type 2 diabetes mellitus.